Carregant...

NEDD8 and HDACs: promising cotargets in AML

In this issue of Blood, Zhou et al have identified synergistic in vitro and in vivo anti–acute myeloid leukemia (AML) activity of the lysine neddylation inhibitor pevonedistat and pan–histone deacetylase (HDAC) inhibitor (pan-HDACI) belinostat and examine the mechanisms responsible for this synergis...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Blood
Autors principals: Bhalla, Kapil N., Fiskus, Warren
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4859193/
https://ncbi.nlm.nih.gov/pubmed/27151736
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-02-699058
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!